Dr. Laura L. Tenner
Claim this profileNebraska Medicine-Bellevue
Area of expertise
Colorectal Cancer
Laura L. Tenner has run 2 trials for Colorectal Cancer. Some of their research focus areas include:
Colon Cancer
Laura L. Tenner has run 2 trials for Colon Cancer. Some of their research focus areas include:
Affiliated Hospitals
Nebraska Medicine-Bellevue
Nebraska Medicine-Village Pointe
Clinical Trials Laura L. Tenner is currently running
Nivolumab + Standard Treatment
for Stomach and Esophageal Cancer
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.
Recruiting
1 award
Phase 2 & 3
20 criteria
Ablative Therapy + Systemic Therapy
for Colorectal Cancer
This phase III trial compares the addition of total ablative therapy to the usual systemic therapy versus the usual systemic therapy alone in treating patients with advanced colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients who are not participating in a study is treatment with intravenous (through a vein) and/or oral medications (systemic therapy) to help stop the cancer sites from getting larger and the spread of the cancer to additional body sites. The ablative local therapy will consist of any combination of very focused, intensive radiotherapy called stereotactic ablative radiotherapy (SABR), surgical resection, or microwave ablation, which is a procedure where a needle is temporarily inserted in the tumor and heat is used to destroy the cancer cells. The addition of ablative local therapy to the usual approach of systemic therapy could be more effective than usual chemotherapy alone by increasing the life of patients with limited metastatic colorectal cancer.
Recruiting
2 awards
Phase 2
More about Laura L. Tenner
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Laura L. Tenner has experience with
- Capecitabine
- Carboplatin
- Cisplatin
- Temozolomide
- Nivolumab
- Dostarlimab
Breakdown of trials Laura L. Tenner has run
Colorectal Cancer
Somatostatinoma
Erectile Dysfunction
Intestinal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Laura L. Tenner specialize in?
Laura L. Tenner focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are dMMR positive.
Is Laura L. Tenner currently recruiting for clinical trials?
Yes, Laura L. Tenner is currently recruiting for 3 clinical trials in Bellevue Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Laura L. Tenner has studied deeply?
Yes, Laura L. Tenner has studied treatments such as Capecitabine, Carboplatin, Cisplatin.
What is the best way to schedule an appointment with Laura L. Tenner?
Apply for one of the trials that Laura L. Tenner is conducting.
What is the office address of Laura L. Tenner?
The office of Laura L. Tenner is located at: Nebraska Medicine-Bellevue, Bellevue, Nebraska 68123 United States. This is the address for their practice at the Nebraska Medicine-Bellevue.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.